Optimizing Oncology Clinical Trials – A Practical Approach

Scimega Research and ACT Oncology are pleased to host this pre-conference workshop entitled Optimizing Oncology Clinical Trials – A Practical Approach. Featuring renowned guest speaker Ken Getz, this interactive ½-day workshop offers you the rare opportunity to share ideas with other industry experts. You will explore several real-world scenarios involving innovative strategies that are helping sponsors overcome the increased complexities and administrative challenges presented by today’s oncology clinical trials.

This is definitely an event you don’t want to miss. Reserve your seat today, as space is limited.

Attendees will receive an Executive Report summarizing the insights and lessons learned from the workshop.

 

WHEN: TUESDAY, FEBRUARY 14TH 2012 (12:00 – 16:00)

WHERE: SAN FRANCISCO AIRPORT MARRIOTT WATERFRONT (Anaheim Room)

 

Workshop Agenda:

12:00 – 13:00

Registration & lunch

Meet and greet: refreshments and buffet lunch


13:00 – 13:45

State-of-the-industry keynote address by Ken Getz

  • Overview of current drug development landscape
  • Strategies to reduce R&D costs & improve performance
  • New directions & new opportunities to innovate
  • Implications for contract & investigative site service providers

13:45 – 15:00

 

 

 

 

 

45 min

30 min

30 min

Practical approach workshop

  • Participants will be split into groups led by facilitators from Scimega Research and ACT Oncology
  • You will then be led through a case study that will provide an opportunity for you to share experiences and best practices on how to improve performance throughout the

 

3 Stages of an Oncology Clinical Trial.

  1. Setting the Stage: site identification, budget & contract management, IRB submissions, pre-study visits, site initiation visit & first patient in. (Team A & Team B)
  2. Active Recruitment & Maintenance: oncology expertise, study quality metrics and # of patients recruited per site (Team A)
  3. Site Close Out: data-crunches, database lock, maintaining site engagement for future studies. (Team B)

15:00 – 16:00

Short wrap-up summarizing Lessons Learned

 

Speakers:

Ken Getz

Ken Getz, MBA

Senior Research Fellow, Tufts Center for the Study of Drug Development

Considered an expert on the global investigative site and CRO markets, R&D management strategy and practices, and patient participation in clinical research, Mr. Getz is a well-known speaker at conferences, university symposia, and corporate programs. He has authored two books, ten book chapters, and more than 150 articles in peer-review and trade journals. Mr. Getz is the founder and chairman of CISCRP, and serves on several boards, including the Clinical Trials Transformation Initiative. He is on the editorial boards of the DIA Journal and Contemporary Clinical Trials, and he writes a regular column for Applied Clinical Trials.

 

Denise

Denise Deakin, R.N. B.Sc.

President & Co-Founder, Scimega Research

Ms. Deakin began her career as a registered nurse and gained pertinent experience through her work on clinical trials in the hospital setting, a career in pharma and finally in her active role as President & Chief Evangelist at Scimega, where she is responsible for developing the Scimega brand by fostering a community of like-minded stakeholders in pursuit of continually improving the oncology clinical trial process.

Ms. Deakin is a frequent speaker at industry conferences, seminars and symposiums. She has 20 years of industry experience, and holds a Nursing Diploma and a BSc. from the University of Montreal.

 

Patricia Devitt Risse, Pharm. D.

President, ACT Oncology

Dr. Devitt Risse brings over two decades of broad-based oncology experience in both global and domestic clinical research environments, including large pharmaceutical companies, biotech companies, and CROs. Armed with these diverse successes, her hard-earned insight, and sophisticated management skills lend stability and long-term commitment to the oncology research community.

Related images

  • Scimega
  • Act Oncology